The Royal Ottawa Mental Health Centre, also known as "ROMHC" or "The Royal" is a 284-bed, 400,000 square-foot psychiatric hospital located in Ottawa, Ontario, Canada.

There are 207 beds in University of Ottawa Institute of Mental Health Research.

During the past decade, University of Ottawa Institute of Mental Health Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Ottawa Institute of Mental Health Research" #1 sponsor was "University of Ottawa" with 9 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "New York State Psychiatric Institute" with 1 trials sponsored, "The Royal Ottawa Mental Health Centre" with 1 trials sponsored and "The Royal's Institute of Mental Health Research" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Ottawa Institute of Mental Health Research" #1 collaborator was "CHEO Research Institute" with 1 trials as a collaborator, "Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal" with 1 trials as a collaborator, "Centre for Addiction and Mental Health" with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "Hopital du Sacre-Coeur de Montreal" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "University of Ottawa Institute of Mental Health Research" are "Depression" (4 trials), "Healthy" (3 trials), "Depressive Disorder, Major" (2 trials), "Schizophrenia" (2 trials) and "ADHD" (1 trials). Many other conditions were trialed in "University of Ottawa Institute of Mental Health Research" in a lesser frequency.

Most popular intervention types in "University of Ottawa Institute of Mental Health Research" are "Drug" (8 trials), "Other" (3 trials), "Behavioral" (2 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aticaprant" (2 trials), "Active Control" (1 trials), "Aerobic Exercise" (1 trials), "Blood Collection" (1 trials) and "CDP-Choline" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Ottawa Institute of Mental Health Research" are 13 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Ottawa Institute of Mental Health Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Ottawa Institute of Mental Health Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Ottawa Institute of Mental Health Research, 4 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".